Seiichi Mizuno

992 total citations
15 papers, 751 citations indexed

About

Seiichi Mizuno is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Physiology. According to data from OpenAlex, Seiichi Mizuno has authored 15 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Public Health, Environmental and Occupational Health and 4 papers in Physiology. Recurrent topics in Seiichi Mizuno's work include Protein Hydrolysis and Bioactive Peptides (14 papers), Consumer Attitudes and Food Labeling (6 papers) and Biochemical effects in animals (4 papers). Seiichi Mizuno is often cited by papers focused on Protein Hydrolysis and Bioactive Peptides (14 papers), Consumer Attitudes and Food Labeling (6 papers) and Biochemical effects in animals (4 papers). Seiichi Mizuno collaborates with scholars based in Japan and United States. Seiichi Mizuno's co-authors include Naoyuki Yamamoto, Takanobu Gotou, Yoshitaka Kajimoto, Keiichi Matsuura, Satoshi Nishimura, Osami Kajimoto, K. Matsuura, Kohji Ohki, Shingo Nishimura and Hidehiko Yokogoshi and has published in prestigious journals such as Journal of Dairy Science, British Journal Of Nutrition and Current Pharmaceutical Design.

In The Last Decade

Seiichi Mizuno

15 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seiichi Mizuno Japan 12 646 227 211 168 165 15 751
Tiina Jauhiainen Finland 9 595 0.9× 282 1.2× 250 1.2× 187 1.1× 130 0.8× 11 808
L Seppo Finland 12 671 1.0× 315 1.4× 268 1.3× 216 1.3× 137 0.8× 17 1.0k
Aleksandra Zambrowicz Poland 16 649 1.0× 96 0.4× 157 0.7× 224 1.3× 203 1.2× 50 860
Orla Power Ireland 6 501 0.8× 52 0.2× 184 0.9× 160 1.0× 135 0.8× 10 668
Marta Pokora Poland 10 464 0.7× 77 0.3× 112 0.5× 162 1.0× 154 0.9× 18 552
Martha Phelan Ireland 8 396 0.6× 69 0.3× 95 0.5× 192 1.1× 83 0.5× 9 489
Timo Rokka Finland 8 485 0.8× 64 0.3× 69 0.3× 278 1.7× 128 0.8× 9 666
Patricia García-Mora Spain 8 424 0.7× 45 0.2× 93 0.4× 247 1.5× 166 1.0× 8 636
Kotaro Aihara Japan 8 337 0.5× 158 0.7× 147 0.7× 94 0.6× 45 0.3× 10 441
M. Zakora United Kingdom 12 466 0.7× 45 0.2× 67 0.3× 359 2.1× 144 0.9× 12 645

Countries citing papers authored by Seiichi Mizuno

Since Specialization
Citations

This map shows the geographic impact of Seiichi Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiichi Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiichi Mizuno more than expected).

Fields of papers citing papers by Seiichi Mizuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seiichi Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiichi Mizuno. The network helps show where Seiichi Mizuno may publish in the future.

Co-authorship network of co-authors of Seiichi Mizuno

This figure shows the co-authorship network connecting the top 25 collaborators of Seiichi Mizuno. A scholar is included among the top collaborators of Seiichi Mizuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seiichi Mizuno. Seiichi Mizuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Inoue, Kaori, et al.. (2009). Release of antihypertensive peptides in miso paste during its fermentation, by the addition of casein. Journal of Bioscience and Bioengineering. 108(2). 111–115. 43 indexed citations
3.
Gotou, Takanobu, et al.. (2009). Purification and identification of proteolytic enzymes from Aspergillus oryzae capable of producing the antihypertensive peptide Ile-Pro-Pro. Journal of Bioscience and Bioengineering. 107(6). 615–619. 18 indexed citations
4.
5.
Ohki, Kohji, Kotaro Aihara, Seiichi Mizuno, et al.. (2005). Effect of Casein Hydrolysate, Prepared with Protease Derived from Aspergillus oryzae, on Subjects with High-Normal Blood Pressure or Mild Hypertension. Journal of Medicinal Food. 8(4). 423–430. 55 indexed citations
6.
Matsuura, Keiichi, Seiichi Mizuno, Satoshi Nishimura, Takanobu Gotou, & Naoyuki Yamamoto. (2005). 米麹菌プロテアーゼを用いるカゼイン加水分解物における抗高血圧性ペプチドVal-Pro-Pro及びIle-Pro-Proの定量分析:LC-MS法. Milk science international/Milchwissenschaft. 60(1). 24–27. 15 indexed citations
7.
Mizuno, Seiichi, Keiichi Matsuura, Takanobu Gotou, et al.. (2005). Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. British Journal Of Nutrition. 94(1). 84–91. 126 indexed citations
8.
Mizuno, Seiichi, John H. Mennear, Keiichi Matsuura, & Bruce K. Bernard. (2005). Studies of the Toxicological Potential of Tripeptides (L-Valyl-L-prolyl-L-proline and L-lsoleucyl-L-prolyl-L-proline): V. A 13-Week Toxicity Study of Tripeptides-Containing Casein Hydrolysate in Male and Female Rats. International Journal of Toxicology. 24(4_suppl). 41–59. 24 indexed citations
9.
10.
Yamamoto, Naoyuki, et al.. (2004). Cloning and expression of an endopeptidase gene from Lactobacillus helveticus CM4 involved in processing antihypertensive peptides. Milk science international/Milchwissenschaft. 59. 593–597. 4 indexed citations
11.
Mizuno, Seiichi, Satoshi Nishimura, K. Matsuura, Takanobu Gotou, & Naoyuki Yamamoto. (2004). Release of Short and Proline-Rich Antihypertensive Peptides from Casein Hydrolysate with an Aspergillus oryzae Protease. Journal of Dairy Science. 87(10). 3183–3188. 100 indexed citations
12.
Ueno, Kentaro, Seiichi Mizuno, & Naoyuki Yamamoto. (2004). Purification and characterization of an endopeptidase that has an important role in the carboxyl terminal processing of antihypertensive peptides in Lactobacillus helveticus CM4. Letters in Applied Microbiology. 39(4). 313–318. 29 indexed citations
13.
Mizuno, Seiichi & Naoyuki Yamamoto. (2004). Antihypertensive peptides from food proteins.. 43–54. 6 indexed citations
14.
Yamamoto, Naoyuki, et al.. (2003). Biogenic Peptides and Their Potential Use. Current Pharmaceutical Design. 9(16). 1345–1355. 141 indexed citations
15.
Shimizu, Hiroshi, et al.. (2002). Effect of Carbon and Nitrogen Additions on Consumption Activity of Apparent Extract of Yeast Cells in a Brewing Process. Journal of the American Society of Brewing Chemists. 60(4). 163–169. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tiina Jauhiainen Breakdown of academic impact, for papers by L Seppo Breakdown of academic impact, for papers by Aleksandra Zambrowicz Breakdown of academic impact, for papers by Orla Power Breakdown of academic impact, for papers by Marta Pokora Breakdown of academic impact, for papers by Martha Phelan Breakdown of academic impact, for papers by Timo Rokka Breakdown of academic impact, for papers by Patricia García-Mora Breakdown of academic impact, for papers by Kotaro Aihara Breakdown of academic impact, for papers by M. Zakora
Rankless by CCL
2026